Gallery
Photos from events, contest for the best costume, videos from master classes.
 |  |
 |  |
 |  |
 |  |
 |  |
 |  |
A Gabapentin lawsuit was filed in 2022, alleging that the manufacturers of Gabapentin failed to warn patients about the potential side effects of the medication, particularly memory loss. However, the overall benefits of Gabapentin in treating various conditions cannot be overlooked. WASHINGTON, D.C. – The U.S. Drug Enforcement Administration (DEA) and the U.S. Food and Drug Administration (FDA) should promptly classify the markedly overprescribed seizure and neuropathic pain drug gabapentin and the closely related drug gabapentin enacarbil as schedule V controlled substances, because they are increasingly being misused, abused, and diverted, leading to dependence and If you or a loved one has attempted suicide, or a loved one has committed suicide while taking Neurontin or has suffered other Neurontin side effects, please send your complaint to a Los Angeles, CA: A $325 million preliminary settlement has been reached by Pfizer Inc and Warner-Lambert Co. LLC and plaintiffs who filed a consumer fraud class action lawsuit over the Neurontin (gabapentin) lawsuits center around severe skin reactions including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Plaintiffs allege that Pfizer failed to adequately warn patients and doctors about these potentially life-threatening risks. Expiration Date: 03/31/2025, 06/30/2025, 08/31/2025, 09/30/2025, 08/31/2025, 11/30/2025, 12/31/2025, 02/28/2026, 05/31/2026 and 08/31/2026. What you should do: If you have the medication, please contact the pharmacy where you got it to verify if the lot number that you received is part of this recall and for further instructions. The active ingredient in Neurontin is gabapentin anhydrous. Plaintiffs allege that Pfizer delayed competition from less expensive generic versions of Neurontin by executing a multifaceted scheme involving, among other things, improperly listing The last Recall Enforcement Report for Gabapentin with NDC 70010-227 was initiated on 07-31-2024 as a Class II recall due to presence of foreign tablets; 3 fused tablets of metformin er 500 mg were found in bottle of gabapentin tablets The latest recall number for this product is D-0634-2024 and the recall is currently ongoing . Hope the Taxotere lawsuit update 2025 gives some news on Taxotere settlement amounts to relieve the tension of the victims. Share your stories of Taxotere injuries with us. We will update the significant occurrences in Taxotere lawsuits soon. Visit our Instagram to get more insights: A $190 million settlement has been reached in New York in a consumer fraud class action lawsuit pending against Pfizer which alleges the pharma giant engaged in tactics to delay market entry of generic versions of its epilepsy drug Neurontin. The lawsuit was filed by purchasers of Neurontin in 2002, claiming Pfizer Last updated on 3 February 2025 (6 weeks ago) by shel46. The majority have the issues after being prescribed the medication gabapentin. Let's chat The information on this page reflects personal experiences shared by our community members. It is not reviewed for medical accuracy and should not replace professional medical advice. Learn about the legal process, your rights, and the significance of joining a class action lawsuit for collective strength. Understanding deadlines, staying informed, and being proactive are key The Pfizer gabapentin lawsuit primarily revolves around allegations that the pharmaceutical giant illegally promoted its drug Neurontin (the brand name for gabapentin) for unapproved uses, also known as off-label marketing. Pregabalin (Lyrica) and gabapentin (Neurontin) are both gabapentinoids, a class of nerve medication initially developed to treat epileptic seizures. Sales of Lyrica and Neurontin tripled a decade ago, when they were touted as safer alternatives to opioids and prescribed off-label for a variety of pain conditions. The active ingredient in Neurontin is gabapentin anhydrous. The lawsuit claimed that Pfizer delayed competition from less expensive generic versions of Neurontin by executing a multifaceted scheme involving, among other things, improperly listing certain patents with the U.S. Food and Drug Administration. engaging in illegal promotion and sales Sometimes the FDA or manufacturers do not take action until a number of plaintiffs come forward with lawsuits. In 1974, complications with Dalkon Shield intrauterine devices showed how effective lawsuits can be in safeguarding public health. Lawsuits claimed the manufacturer marketed the device aggressively even though it was aware of safety What Is Neurontin? Gabapentin, an anti-seizure drug marketed by Pfizer Laboratories in the United States under the trademark name Neurontin, has been the subject of numerous claims of malfeasance in gabapentin side effects lawsuits, with the Pfizer company intentionally and knowingly marketing the medication for uses not approved by the FDA (Food and Drug Administration). Explore the potential for seeking compensation in gabapentin-related memory loss cases, including legal grounds, evidence, and filing deadlines. Gabapentin, a medication prescribed for nerve pain and seizures, is under scrutiny due to claims of memory loss linked to its use. The plaintiffs in the Neurontin class action lawsuit alleged that Pfizer delayed competition from generic producers of the drug, gabapentin anhydrous, which Pfizer sold under the name Neurotin, by exercising a monopoly over the medicine. Discussion of the legal issues
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
| |
| |
| |
| |
| |
| |